In a regulatory filing, Tandem Diabetes (TNDM) disclosed that its COO Jean-Claude Kyrillos bought 10.5K shares of common stock on March 7th in a total transaction size of $191K. Shares are up 2.5% afterhours at $18.33.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TNDM:
- Tandem Diabetes Care: A Buy Rating Backed by Growth Potential and Valuation Opportunity
- Tandem, Check Point, Chipotle, FTAI, AES: Trending by Analysts
- Royal Caribbean upgraded, AppLovin downgraded: Wall Street’s top analyst calls
- Tandem Diabetes downgraded to Equal Weight from Overweight at Morgan Stanley
- Tandem Diabetes downgraded to Neutral from Buy at Citi